{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:49:20Z","timestamp":1747165760464,"version":"3.40.5"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedic Science"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jos.2023.05.008","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T19:54:18Z","timestamp":1685735658000},"page":"1108-1111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Artifactual hypoglycaemia may be common in patients with soft tissue sarcoma who received pegfilgrastim-supported chemotherapy"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1099-7436","authenticated-orcid":false,"given":"Tomoki","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Asanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohito","family":"Hagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Sudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jos.2023.05.008_bib2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJMra041866","article-title":"Soft-tissue sarcomas in adults","volume":"353","author":"Clark","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jos.2023.05.008_bib3","article-title":"SELNET clinical practice guidelines for soft tissue sarcoma and GIST","volume":"10","author":"Blay","year":"2022","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"10.1016\/j.jos.2023.05.008_bib4","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1200\/JCO.2011.37.7218","article-title":"Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group","volume":"30","author":"Gronchi","year":"2012","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.jos.2023.05.008_bib5","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1200\/JCO.2001.19.5.1238","article-title":"Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial","volume":"19","author":"Frustaci","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.jos.2023.05.008_bib6","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1470-2045(17)30334-0","article-title":"Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial","volume":"18","author":"Gronchi","year":"2017","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jos.2023.05.008_bib7","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1186\/s12885-019-6114-2","article-title":"Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304","volume":"19","author":"Tanaka","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jos.2023.05.008_bib8","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.2147\/DDDT.S275526","article-title":"Clinical outcome of systemic treatment for advanced soft tissue sarcoma: real life perspective in Japan","volume":"14","author":"Nakamura","year":"2020","journal-title":"Drug Des Dev Ther"},{"issue":"8","key":"10.1016\/j.jos.2023.05.008_bib9","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41416-022-01912-5","article-title":"Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II\/III study JCOG1306","volume":"127","author":"Tanaka","year":"2022","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.jos.2023.05.008_bib10","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/jps.20024","article-title":"Polyethylene glycol modification of filgrastim results in decreased renal clearance of the protein in rats","volume":"93","author":"Yang","year":"2004","journal-title":"J\u00a0Pharm Sci"},{"issue":"5","key":"10.1016\/j.jos.2023.05.008_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/11586040-000000000-00000","article-title":"Pharmacokinetics and pharmacodynamics of pegfilgrastim","volume":"50","author":"Yang","year":"2011","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.1016\/j.jos.2023.05.008_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.33594\/000000245","article-title":"The critical role of cell metabolism for essential neutrophil functions","volume":"54","author":"Curi","year":"2020","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"10.1016\/j.jos.2023.05.008_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1507\/endocrj.50.481","article-title":"Leukocytosis-induced artifactual hypoglycemia","volume":"50","author":"Ybarra","year":"2003","journal-title":"Endocr J"},{"issue":"9","key":"10.1016\/j.jos.2023.05.008_bib14","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/rheumatology\/kez118","article-title":"Clinical impact of artifactual hypoglycemia and its diagnosis at the bedside","volume":"58","author":"Drenthen","year":"2019","journal-title":"Rheumatology"},{"issue":"43","key":"10.1016\/j.jos.2023.05.008_bib15","doi-asserted-by":"crossref","first-page":"E1660","DOI":"10.1503\/cmaj.210191","article-title":"Artifactual hypoglycemia in patients with sickle cell anemia","volume":"193","author":"Wang","year":"2021","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"10","key":"10.1016\/j.jos.2023.05.008_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107976","article-title":"Hypoglycemia symptoms are reduced in hospitalized patients with diabetes","volume":"35","author":"Criner","year":"2021","journal-title":"J\u00a0Diabet Complicat"},{"issue":"3","key":"10.1016\/j.jos.2023.05.008_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.jos.2023.05.008_bib18","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2009.24.8872","article-title":"Phase II, randomized, open-label study of pegfilgrastim-supported VDC\/IE chemotherapy in pediatric sarcoma patients","volume":"28","author":"Spunt","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.jos.2023.05.008_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.503","article-title":"Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pegleg\u00ae, a pegfilgrastim biosimilar in health subjects","volume":"7","author":"Roth","year":"2019","journal-title":"Pharmacol Res Perspect"}],"container-title":["Journal of Orthopaedic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265823001367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265823001367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T18:59:36Z","timestamp":1729537176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0949265823001367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0949265823001367"],"URL":"https:\/\/doi.org\/10.1016\/j.jos.2023.05.008","relation":{},"ISSN":["0949-2658"],"issn-type":[{"type":"print","value":"0949-2658"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artifactual hypoglycaemia may be common in patients with soft tissue sarcoma who received pegfilgrastim-supported chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedic Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jos.2023.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}